Tandem Diabetes Care Inc
General ticker "TNDM" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.1B
Tandem Diabetes Care Inc follows the US Stock Market performance with the rate: 31.1%.
Estimated limits based on current volatility of 3.5%: low 33.53$, high 35.98$
Factors to consider:
- US accounted for 74.2% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [14.83$, 34.27$]
- 2024-12-30 to 2025-12-30 estimated range: [15.13$, 34.03$]
Financial Metrics affecting the TNDM estimates:
- Negative: Non-GAAP EPS, $ of -1.58 <= 0.10
- Negative: Operating profit margin, % of -23.78 <= 1.03
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -1.96 <= 2.35
- Negative: Industry operating profit margin (median), % of -26.46 <= 2.14
- Positive: -3.48 < Investing cash flow per share, $ of -1.32
Short-term TNDM quotes
Long-term TNDM plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $702.80MM | $801.22MM | $747.72MM |
Operating Expenses | $693.99MM | $863.03MM | $980.95MM |
Operating Income | $8.81MM | $-61.81MM | $-233.23MM |
Non-Operating Income | $7.09MM | $-31.04MM | $12.98MM |
Interest Expense | $4.31MM | $4.31MM | $9.88MM |
R&D Expense | $92.05MM | $139.11MM | $169.67MM |
Income(Loss) | $15.90MM | $-92.85MM | $-220.25MM |
Taxes | $0.34MM | $1.74MM | $2.36MM |
Profit(Loss) | $15.57MM | $-94.59MM | $-222.61MM |
Stockholders Equity | $433.11MM | $439.95MM | $313.63MM |
Inventory | $68.55MM | $111.12MM | $157.94MM |
Assets | $905.14MM | $1,052.79MM | $952.66MM |
Operating Cash Flow | $111.36MM | $50.46MM | $-31.81MM |
Capital expenditure | $23.51MM | $42.95MM | $51.60MM |
Investing Cash Flow | $-186.88MM | $33.17MM | $-85.74MM |
Financing Cash Flow | $51.93MM | $16.88MM | $4.11MM |
Earnings Per Share* | $0.25 | $-1.47 | $-3.43 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.